Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Sep 18, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Halozyme Therapeutics, Inc.
|
0
|
$39.55 | -$916,095.53 |
—
| 173.76K | +1 |
Sep 17 - Sep 18
|
Scheduled
| |||||
Halozyme Therapeutics, Inc.
|
0
|
$36.50 | -$1,357,690.00 |
—
| 676.74K |
Sep 10 - Sep 12
|
Scheduled
| ||||||
Halozyme Therapeutics, Inc.
| 5.58K |
$18.41 | $102,727.80 | +3.32% | 173.76K | +1 |
Aug 27
| ||||||
Halozyme Therapeutics, Inc.
|
0
|
$35.51 | -$1,298,350.68 |
—
| 676.74K |
Aug 13 - Aug 15
|
Scheduled
| ||||||
Halozyme Therapeutics, Inc.
| -29.88K |
$56.53 | -$1,689,293.70 | -29.95% | 69.87K |
Aug 12 - Aug 14
| |||||||
Halozyme Therapeutics, Inc.
|
0
|
$33.33 | -$867,069.48 |
—
| 168.18K | +1 |
Jul 23 - Jul 24
|
Scheduled
| |||||
Halozyme Therapeutics, Inc.
|
0
|
$38.22 | -$157,161.80 |
—
| 15.48K | +1 |
Jul 22
|
Scheduled
| |||||
Halozyme Therapeutics, Inc.
|
0
|
$37.22 | -$882,940.00 |
—
| 15.48K | +1 |
Jun 26 - Jun 28
|
Scheduled
| |||||
Halozyme Therapeutics, Inc.
|
0
|
$28.77 | -$413,160.00 |
—
| 168.18K | +1 |
Jun 18
|
Scheduled
| |||||
Halozyme Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Jun 12
| ||||||
Halozyme Therapeutics, Inc.
| -20.00K |
$50.32 | -$1,006,300.00 | -16.70% | 99.75K |
Jun 11 - Jun 12
| |||||||
Halozyme Therapeutics, Inc.
|
0
|
$26.69 | -$743,280.00 |
—
| 168.18K | +1 |
May 21 - May 22
|
Scheduled
| |||||
Halozyme Therapeutics, Inc.
| 6.5K |
—
|
—
| +5.74% | 119.75K |
Apr 25
| |||||||
Halozyme Therapeutics, Inc.
| 6.5K |
—
|
—
| +45.55% | 20.77K |
Apr 25
| |||||||
Halozyme Therapeutics, Inc.
| 6.5K |
—
|
—
| +3.48% | 193.5K |
Apr 25
| |||||||
Halozyme Therapeutics, Inc.
| 6.5K |
—
|
—
|
∞
| 6.5K |
Apr 25
| |||||||
Halozyme Therapeutics, Inc.
| 6.5K |
—
|
—
| +13.80% | 53.61K |
Apr 25
| |||||||
Halozyme Therapeutics, Inc.
| 6.5K |
—
|
—
| +70.26% | 15.75K |
Apr 25
| |||||||
Halozyme Therapeutics, Inc.
| 6.5K |
—
|
—
| +16.14% | 46.79K |
Apr 25
| |||||||
Halozyme Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Halozyme Therapeutics, Inc.
|
0
|
$23.27 | -$606,190.00 |
—
| 168.18K | +1 |
Apr 16 - Apr 17
|
Scheduled
| |||||
Halozyme Therapeutics, Inc.
| 11.62K |
$11.20 | $130,160.18 | +7.42% | 168.18K | +1 |
Mar 26
| ||||||
Halozyme Therapeutics, Inc.
|
0
|
$26.67 | -$611,761.96 |
—
| 156.56K | +1 |
Mar 12 - Mar 13
|
Scheduled
| |||||
Halozyme Therapeutics, Inc.
| -12.53K |
$23.93 | -$734,333.18 | -7.41% | 156.56K | +1 |
Feb 27 - Feb 28
|
Scheduled
| |||||
Halozyme Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 23
| ||||||
Halozyme Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 23
| ||||||
Halozyme Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 23
| ||||||
Halozyme Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 23
| |||||||
Halozyme Therapeutics, Inc.
| 5.12K |
$36.10 | -$189,777.70 | +3.12% | 169.09K | +1 |
Feb 16
| ||||||
Halozyme Therapeutics, Inc.
| 2.22K |
$36.10 | -$93,029.70 | +23.45% | 11.68K | +1 |
Feb 16
| ||||||
Halozyme Therapeutics, Inc.
| 4.82K |
$36.10 | -$202,196.10 | +45.23% | 15.48K | +1 |
Feb 16
| ||||||
Halozyme Therapeutics, Inc.
| 17.52K |
$36.10 | -$735,068.20 | +2.66% | 676.74K |
Feb 16
| |||||||
Halozyme Therapeutics, Inc.
| 6.83K |
$35.91 | -$180,986.40 | +4.34% | 163.97K | +1 |
Feb 15
| ||||||
Halozyme Therapeutics, Inc.
| 568 |
$35.91 | -$24,634.26 | +5.63% | 10.66K | +1 |
Feb 15
| ||||||
Halozyme Therapeutics, Inc.
| 21.22K |
$35.91 | -$885,361.05 | +3.33% | 659.22K |
Feb 15
| |||||||
Halozyme Therapeutics, Inc.
| 5.23K |
$35.49 | -$102,956.49 | +3.44% | 157.14K | +1 |
Feb 10
| ||||||
Halozyme Therapeutics, Inc.
| 1.02K |
$35.49 | -$52,418.73 | +11.31% | 10.09K | +1 |
Feb 10
| ||||||
Halozyme Therapeutics, Inc.
| 14.34K |
$35.49 | -$601,307.07 | +2.30% | 638K |
Feb 10
| |||||||
Halozyme Therapeutics, Inc.
|
0
|
$24.04 | -$478,600.00 |
—
| 151.91K | +1 |
Jan 16 - Jan 17
|
Scheduled
| |||||
Halozyme Therapeutics, Inc.
| 4.65K |
$35.78 | -$105,801.46 | +96.82% | 9.46K | +1 |
Jan 3
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.